Big Pharma partners join initiative to drive equity and inclusion in digital trials

As digital trials picked up steam amid the pandemic, some said the technology could also be used to address biopharma’s historic lack of diversity in the clinic. But if implemented the wrong way, it could also exacerbate the problem, the Digital Medicine Society (DiMe) warns.

That’s why DiMe is looking...

Click to view original post